UK | pharmaphorum

UK

News

Controversial US data firm Palantir could manage UK's ailing...

US data analysis company Palantir Technologies could be drafted in to manage the UK government’s troubled COVID-19 Test and Trace programme, according to press reports.

Views & Analysis

Ipsen’s UK & Ireland MD on adapting business to COVID-19

Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining

Views & Analysis

What HCPs Think about schools reopening

In our latest article in the What HCPs Think series, CREATION.co’s Jamie Doggett analyses the soc

News

NICE changes its mind on Novartis’ progressive MS drug Mayze...

UK cost-effectiveness agency NICE has backed Novartis’ Mayzent for secondary progressive multiple sclerosis (SPMS), after turning it down earlier this year in draft guidance.

News

UK pledges £571m to equitable COVID-19 vaccine access scheme

UK Prime Minister Boris Johnson has told the UN General Assembly that the UK will donate £571 million ($735 million) to the COVAX scheme aimed at distributing COVID-19 vaccines fairly aroun

News

UK extends COVID-19 vaccine supply deal with Valneva

The UK government has signed a €1.4 billion ($1.66 billion) order for up to 190 million doses of a coronavirus vaccine in development at French company Valneva.

Controversial US data firm Palantir could manage UK's ailing...

Ipsen’s UK & Ireland MD on adapting business to COVID-19

What HCPs Think about schools reopening

NICE changes its mind on Novartis’ progressive MS drug Mayze...

UK pledges £571m to equitable COVID-19 vaccine access scheme

UK extends COVID-19 vaccine supply deal with Valneva

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

UK

Editor's Picks